We evaluated the expression of CHI3L1 along with clinical parameters and neutrophil infiltration by using the publicly available dataset (GSE128959) and a bladder cancer cohort undergoing chemotherapy. This evidence concerns the gene CHI3L1 and urinary bladder carcinoma.